2021 annual financial data
Stoke Therapeutics 2021 Net margin
Direct answer
Net margin was -2,823.7%.
Operating income was -86,065,000 USD and net income was -84,711,000 USD.
Operating cash flow was -66,907,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- -86,065,000 USD
- Net income
- -84,711,000 USD
- Operating cash flow
- -66,907,000 USD